Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol for opioid withdrawal suppression
NCT00142896Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Feb 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tramadol in opioid use disorder (OUD) (4 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Opioid withdrawal symptoms, Opioid agonist effects and 1 more. Started Feb 2005; status: completed.
02
Drugs
tramadol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00142896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142896.